Closure times measured by the platelet function analyzer PFA-100® Are longer in neonatal blood compared to cord blood samples

Neonatology

Volumn 97, Issue 3, 2010, Pages 242-249

  Saxonhouse, Matthew A ^a,d   Garner, Rachel ^a   Mammel, Lauren ^a   Li, Qin ^b   Muller, Keith E ^b   Greywoode, Jewel ^a   Miller, Cindy ^a   Sola Visner, Martha ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d Carolinas Medical Center NorthEast   (United States)

Author keywords

Cord blood; PFA 100 ; Platelet function; Platelets; Premature infant

Indexed keywords

ADRENALIN;

ADULT; AGED; ANALYZER; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; INFANT; MEDICAL INSTRUMENTATION; NEWBORN; PREMATURITY; PRIORITY JOURNAL; THROMBOCYTE FUNCTION; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CELL MEMBRANE PERMEABILITY; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MIDDLE AGED; PLATELET FUNCTION TESTS; SHEAR STRENGTH; TERM BIRTH; TIME FACTORS; YOUNG ADULT;

EID: 70350542688     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000253755     Document Type: Article

References (39)

1. Ward RM, Beachy JC: Neonatal complications following preterm birth. BJOG 2003; 110(suppl 20):8-16.
2. Israels SJ, Odaibo FS, Robertson C, McMillan EM, McNicol A: Deficient thromboxane synthesis and response in platelets from premature infants. Pediatr Res 1997; 41: 218-223.
3. Louden KA, Broughton PF, Heptinstall S, Fox SC, Tuohy P, O'Callaghan C, Mitchell JR, Symonds EM: Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Br J Obstet Gynaecol 1994; 101: 203-208.
4. Rajasekhar D, Barnard MR, Bednarek FJ, Michelson AD: Platelet hyporeactivity in very low birth weight neonates. Thromb Haemost 1997; 77: 1002-1007.
5. Rajasekhar D, Kestin AS, Bednarek FJ, Ellis PA, Barnard MR, Michelson AD: Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thromb Haemost 1994; 72: 957-963.
6. Bednarek FJ, Bean S, Barnard MR, Frelinger AL, Michelson AD: The platelet hyporeactivity of extremely low birth weight neonates is age-dependent. Thromb Res 2009; 124: 42-45.
7. Cvirn G, Kutschera J, Wagner T, Ferstl U, Vrecko K, Hallstrom S, Juergens G, Koestenberger M: Collagen/endogenous thrombininduced platelet aggregation in cord versus adult whole blood. Neonatology 2008; 95: 187-192.
8. Andrew M: The hemostatic system in the infant; in Nathan DG OF (ed): Hematology of Infancy and Childhood. Philadelphia, WB Saunders, 1992, pp 119.
9. Andrew M, Paes B, Bowker J, Vegh P: Evaluation of an automated bleeding time device in the newborn. Am J Hematol 1990; 35: 275-277.
10. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Suc JM, Boneu B: Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol 1985; 59: 139-148.
11. Feusner JH: Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic. Am J Clin Pathol 1980; 74: 73-77.
12. Del Vecchio A, Latini G, Henry E, Christensen RD: Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 2008; 28: 427-431.
13. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA: Description of an in vitro platelet function analyzer -PFA-100. Semin Thromb Hemost 1995; 21: 106-112.
14. Favaloro EJ: Utility of the pfa-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 2001; 7: 170-179.
15. Podda GM, Bucciarelli P, Lussana F, Lecchi A, Cattaneo M: Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time. J Thromb Haemost 2007; 5: 2393-2398.
16. Posan E, McBane RD, Grill DE, Motsko CL, Nichols WL: Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 2003; 90: 483-490.
17. Quiroga T, Goycoolea M, Munoz B, Morales M, Aranda E, Panes O, Pereira J, Mezzano D: Template bleeding time and pfa-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2004; 2: 892-898.
18. Boudewijns M, Raes M, Peeters V, Mewis A, Cartuyvels R, Magerman K, Rummens JL: Evaluation of platelet function on cord blood in 80 healthy term neonates using the platelet function analyser (PFA-100); shorter in vitro bleeding times in neonates than adults. Eur J Pediatr 2003; 162: 212-213.
19. Carcao MD, Blanchette VS, Dean JA, He L, Kern MA, Stain AM, Sparling CR, Stephens D, Ryan G, Freedman J, Rand ML: The platelet function analyzer (PFA-100): a novel invitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101: 70-73.
20. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M: Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatr 2001; 138: 116-119.
21. Roschitz B, Sudi K, Kostenberger M, Muntean W: Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr 2001; 90: 664-670.
22. Edwards RM, Naik-Mathuria BJ, Gay AN, Olutoye OO, Teruya J: Parameters of thromboelastography in healthy newborns. Am J Clin Pathol 2008; 130: 99-102.
23. Sheffield MJ, Schmutz N, Lambert DK, Henry E, Christensen RD: Ibuprofen lysine administration to neonates with a patent ductus arteriosus: effect on platelet plug formation assessed by in vivo and in vitro measurements. J Perinatol 2009; 29: 39-43.
24. Sutton L, Bajuk B, Berry G, Sayer GP, Richardson V, Henderson-Smart DJ: Score of neonatal acute physiology as a measure of illness severity in mechanically ventilated term babies. Acta Paediatr 2002; 91: 415-423.
25. Perel JM, Just S, Rowell J, Williams B, Kennedy GA: Utility of the PFA-100 analyser in the evaluation of primary haemostasis in a paediatric population. Int J Lab Hematol 2007; 29: 480-481.
26. Chalmers EA, Williams MD, Richards M, Brown SA, Liesner R, Thomas A, Vidler V, Pasi KJ, Hill FG: Management of neonates with inherited bleeding disorders - a survey of current UK practice. Haemophilia 2005; 11: 186-187.
27. Andrews NP, Broughton Pipkin F, Heptinstall S: Blood platelet behaviour in mothers and neonates. Thromb Haemost 1985; 53: 428-432.
28. Kettner SC, Pollak A, Zimpfer M, Seybold T, Prusa AR, Herkner K, Kuhle S: Heparinasemodified thrombelastography in term and preterm neonates. Anesth Analg 2004; 98: 1650-1652.
29. Coulter SA, Cannon CP, Ault KA, Antman EM, Van de Werf F, Adgey AA, Gibson CM, Giugliano RP, Mascelli MA, Scherer J, Barnathan ES, Braunwald E, Kleiman NS: High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (thrombolysis in myocardial infarction) 14. Circulation 2000; 101: 2690-2695.
30. Amato M, Fauchere JC, Hermann U Jr: Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage. Neuropediatrics 1988; 19: 154-157.
31. Setzer ES, Webb IB, Wassenaar JW, Reeder JD, Mehta PS, Eitzman DV: Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant. J Pediatr 1982; 100: 599-605.
32. Corazza MD, Davis RF, Merritt T, Bejar R, Cvetnic W: Prolonged bleeding time in preterm infants receiving indomethacin for patent ducturs arteriosus. J Pediatr 1984; 105: 292-296.
33. Del Vecchio A, Sola M: Performing and interpreting the bleeding time in the neonatal intensive care unit. Clin Perinatol 2000; 27: 643-654.
34. Del Vecchio A, Sullivan S, Christensen R, Schbler K, Hutson A, Chevuru S, et al: Indomethacin prolongs the bleeding time in neonates significantly more than ibuprofen. Pediatr Res 2002; 51: 446A.
35. Burroughs SF, Johnson GJ: Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin. Blood 1990; 75: 1473-1480.
36. Dijkmans BA, Van Der Meer JW, Boekhout-Mussert MJ, Zaal-De Jong M, Mattie H: Prolonged bleeding time during azlocillin therapy. J Antimicrob Chemother 1980; 6: 554-556.
37. Fass R, Copelan E, Brandt J, Moeschberger M, Ashton J: Platelet-mediated bleeding caused by broad-spectrum penicillins. J Infect Dis 1987; 155: 1242-1248.
38. Gentry LO, Wood BA, Natelson EA: Effects of apalcillin on platelet function in normal volunteers. Antimicrob Agents Chemother 1985; 27: 683-684.
39. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Sola-Visner MC, Lambert DK, Kiehn TI, Ainsworth S: Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006; 26: 348-353.